Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Parmar

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Indian Journal of Tuberculosis|March 18, 2019
N-TB: A mobile-based application to simplify nutritional assessment, counseling and care of patients with tuberculosis in IndiaAnurag Bhargava, Madhavi Bhargava, Tripti Pande, et al.
BMJ Open|August 29, 2022
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocolChandrasekaran Padmapriyadarsini, Bella Devaleenal, C Ponnuraja, et al.
Expert Review of Respiratory Medicine|December 14, 2020
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020)Kuldeep Singh Sachdeva, Malik Parmar, Yogesh Patel, et al.
The Indian Journal of Tuberculosis|June 24, 2018
Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening interventionChakrapani Chatla, Jyoti Jaju, Shanta Achanta, et al.
The Pediatric Infectious Disease Journal|February 14, 2022
Feasibility of a "Salvage Regimen" Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric TuberculosisIra Shah, Sonu Antony, Akanksha Jaiswal, et al.
WHO South-East Asia Journal of Public Health|June 14, 2017
Innovative social protection mechanism for alleviating catastrophic expenses on multidrug-resistant tuberculosis patients in Chhattisgarh, IndiaDebashish Kundu, Vijendra Katre, Kamalpreet Singh, et al.
Bulletin of the World Health Organization|May 30, 2024
Health literacy and tuberculosis control: systematic review and meta-analysisArohi Chauhan, Malik Parmar, Girish C Dash, et al.
Plos One|April 21, 2018
Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in IndiaHemant Deepak Shewade, Arun M Kokane, Akash Ranjan Singh, et al.
Emerging Infectious Diseases|February 21, 2018
Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, IndiaPoonam Ramesh Naik, Patrick K Moonan, Abhay Subhashrao Nirgude, et al.
Lung India : Official Organ of Indian Chest Society|December 31, 2023
Effect of delamanid on interim outcomes of bacteriological conversion amongst pediatric drug resistant tuberculosis cases in IndiaDhruv Kalawadia, Darshini Gandhi, Tsering Y Dirkhipa, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Indian Journal of Tuberculosis|March 18, 2019
N-TB: A mobile-based application to simplify nutritional assessment, counseling and care of patients with tuberculosis in IndiaAnurag Bhargava, Madhavi Bhargava, Tripti Pande, et al.
BMJ Open|August 29, 2022
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocolChandrasekaran Padmapriyadarsini, Bella Devaleenal, C Ponnuraja, et al.
Expert Review of Respiratory Medicine|December 14, 2020
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020)Kuldeep Singh Sachdeva, Malik Parmar, Yogesh Patel, et al.
The Indian Journal of Tuberculosis|June 24, 2018
Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening interventionChakrapani Chatla, Jyoti Jaju, Shanta Achanta, et al.
The Pediatric Infectious Disease Journal|February 14, 2022
Feasibility of a "Salvage Regimen" Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric TuberculosisIra Shah, Sonu Antony, Akanksha Jaiswal, et al.
WHO South-East Asia Journal of Public Health|June 14, 2017
Innovative social protection mechanism for alleviating catastrophic expenses on multidrug-resistant tuberculosis patients in Chhattisgarh, IndiaDebashish Kundu, Vijendra Katre, Kamalpreet Singh, et al.
Bulletin of the World Health Organization|May 30, 2024
Health literacy and tuberculosis control: systematic review and meta-analysisArohi Chauhan, Malik Parmar, Girish C Dash, et al.
Plos One|April 21, 2018
Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in IndiaHemant Deepak Shewade, Arun M Kokane, Akash Ranjan Singh, et al.
Emerging Infectious Diseases|February 21, 2018
Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, IndiaPoonam Ramesh Naik, Patrick K Moonan, Abhay Subhashrao Nirgude, et al.
Lung India : Official Organ of Indian Chest Society|December 31, 2023
Effect of delamanid on interim outcomes of bacteriological conversion amongst pediatric drug resistant tuberculosis cases in IndiaDhruv Kalawadia, Darshini Gandhi, Tsering Y Dirkhipa, et al.
Pageof 4